Investors

Kevin Giese is the founding President and CEO of Medwell Capital, a biotechnology company dedicated to the development and commercialization of innovative therapies, with an emphasis on the treatment of Multiple Sclerosis. Kevin has a B.A. in economics, a law degree, and an M.B.A.

Kevin practiced law in Vancouver, has been the past president of Mr. Lube U.S. and was a director and the chief financial officer for NQL Drilling Tools (a TSX listed oilfield equipment company). Kevin has in the past served on the board of a number of private and public companies and is currently a member of the Board of Directors of BioAlberta.